Entrada Therapeutics, Inc. Common Stock
$6.620
USD
Last updated on --.
24h volume426.48K
24h highest6.8600 USD
24h lowest6.5300 USD
24h Price movement-1.19%
TRDA recent prices
24 Hours
-1.19%-$0.08
30 days
-48.61%-$6.266
60 days
-43.72%-$5.146
90 days
-44.48%-$5.306
Key data
Previous close6.7000 USD
Market cap234.48M USD
Volume426.48K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-4.2800 USD
Net income (FY)-166.12M USD
Revenue (FY)5.74M USD
Last report date7 May 2026
About Entrada Therapeutics, Inc. Common Stock
HeadquartersBOSTON
Employees (FY)152.00
Revenue per employee (FY)37.75K USD
Net income per employee (FY)-1.09M USD
Listed onNasdaq
TRDA conversion tables
 |  |
|---|---|
| 0.5 TRDA | 3.310 USD |
| 1 TRDA | 6.620 USD |
| 5 TRDA | 33.1 USD |
| 10 TRDA | 66.2 USD |
| |
|---|---|
| 0.5 USD | 0.075529 TRDA |
| 1 USD | 0.15106 TRDA |
| 5 USD | 0.75529 TRDA |
| 10 USD | 1.510 TRDA |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
TRDA is trading at $6.620, -1.19% over the last 24 hours. Track live moves on the price chart at the top of this page.
The TRDA stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. TRDA is currently trading at $6.620, -1.19% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on TRDA price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. TRDA's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from TRDA; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against TRDA's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Entrada Therapeutics, Inc. Common Stock's market cap is currently 234.48M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume426.48K
24h highest6.8600 USD
24h lowest6.5300 USD
24h Price movement-1.19%
Start trade with TRDA Perpetual
Sign up to trade